Literature DB >> 18641129

Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release.

Jez G Carlton1, Monica Agromayor, Juan Martin-Serrano.   

Abstract

The ESCRT machinery functions in topologically equivalent membrane fission events, namely multivesicular body formation, the terminal stages of cytokinesis and HIV-1 release. Here, we show that the ESCRT-III-binding protein Alix is recruited to the midbody of dividing cells through binding Cep55 via an evolutionarily conserved peptide. Disruption of Cep55/Alix/ESCRT-III interactions causes formation of aberrant midbodies and cytokinetic failure, demonstrating an essential role for these proteins in midbody morphology and cell division. We also show that the C terminus of Alix encodes a multimerization activity that is essential for its function in Alix-dependent HIV-1 release and for interaction with Tsg101. Last, we demonstrate that overexpression of Chmp4b and Chmp4c differentially inhibits HIV-1 release and cytokinesis, suggesting possible reasons for gene expansion within the mammalian Class E VPS pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641129      PMCID: PMC2492449          DOI: 10.1073/pnas.0802008105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Structural basis for budding by the ESCRT-III factor CHMP3.

Authors:  Tadeusz Muzioł; Estela Pineda-Molina; Raimond B Ravelli; Alessia Zamborlini; Yoshiko Usami; Heinrich Göttlinger; Winfried Weissenhorn
Journal:  Dev Cell       Date:  2006-06       Impact factor: 12.270

Review 3.  The ESCRT complexes: structure and mechanism of a membrane-trafficking network.

Authors:  James H Hurley; Scott D Emr
Journal:  Annu Rev Biophys Biomol Struct       Date:  2006

4.  The novel centrosomal associated protein CEP55 is present in the spindle midzone and the midbody.

Authors:  Isabel Martinez-Garay; Amin Rustom; Hans-Hermann Gerdes; Kerstin Kutsche
Journal:  Genomics       Date:  2006-01-10       Impact factor: 5.736

5.  Clues to CD2-associated protein involvement in cytokinesis.

Authors:  Pascale Monzo; Nils C Gauthier; Frédérique Keslair; Agnès Loubat; Christine M Field; Yannick Le Marchand-Brustel; Mireille Cormont
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

6.  Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.

Authors:  Megan Fabbro; Bin-Bing Zhou; Mikiko Takahashi; Boris Sarcevic; Preeti Lal; Mark E Graham; Brian G Gabrielli; Phillip J Robinson; Erich A Nigg; Yoshitaka Ono; Kum Kum Khanna
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

7.  Terminal phase of cytokinesis in D-98s cells.

Authors:  J M Mullins; J J Biesele
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

8.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  A bipartite late-budding domain in human immunodeficiency virus type 1.

Authors:  Juan Martin-Serrano; Paul D Bieniasz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway.

Authors:  Juan Martin-Serrano; Scott W Eastman; Wayne Chung; Paul D Bieniasz
Journal:  J Cell Biol       Date:  2004-12-28       Impact factor: 10.539

View more
  112 in total

1.  Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins.

Authors:  Xi Zhou; Jiali Si; Joe Corvera; Gary E Gallick; Jian Kuang
Journal:  Biochem J       Date:  2010-12-15       Impact factor: 3.857

Review 2.  Proline-rich regions and motifs in trafficking: from ESCRT interaction to viral exploitation.

Authors:  Xuefeng Ren; James H Hurley
Journal:  Traffic       Date:  2011-05-13       Impact factor: 6.215

3.  CC2D1A is a regulator of ESCRT-III CHMP4B.

Authors:  Nicolas Martinelli; Bettina Hartlieb; Yoshiko Usami; Charles Sabin; Aurelien Dordor; Nolwenn Miguet; Sergiy V Avilov; Euripedes A Ribeiro; Heinrich Göttlinger; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

Review 4.  Dynamics of ESCRT proteins.

Authors:  Nolwenn Jouvenet
Journal:  Cell Mol Life Sci       Date:  2012-06-06       Impact factor: 9.261

Review 5.  The ESCRT complexes.

Authors:  James H Hurley
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-07-23       Impact factor: 8.250

6.  Conformational Changes in the Endosomal Sorting Complex Required for the Transport III Subunit Ist1 Lead to Distinct Modes of ATPase Vps4 Regulation.

Authors:  Jason Tan; Brian A Davies; Johanna A Payne; Linda M Benson; David J Katzmann
Journal:  J Biol Chem       Date:  2015-10-29       Impact factor: 5.157

Review 7.  Atypical regulation of G protein-coupled receptor intracellular trafficking by ubiquitination.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Curr Opin Cell Biol       Date:  2013-12-07       Impact factor: 8.382

Review 8.  Molecular control of animal cell cytokinesis.

Authors:  Juan Pablo Fededa; Daniel W Gerlich
Journal:  Nat Cell Biol       Date:  2012-05-02       Impact factor: 28.824

Review 9.  Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Authors:  J Jeffery; D Sinha; S Srihari; M Kalimutho; K K Khanna
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 10.  Resurrecting remnants: the lives of post-mitotic midbodies.

Authors:  Chun-Ting Chen; Andreas W Ettinger; Wieland B Huttner; Stephen J Doxsey
Journal:  Trends Cell Biol       Date:  2012-12-11       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.